Data / Form D filings / Brogent China Life Sciences Ltd.
Brogent China Life Sciences Ltd.: Form D filing
Brogent China Life Sciences Ltd., a health care company in Grand Cayman, Cayman Islands, filed a Form D with the SEC in 2019. The latest, on February 5, 2019, reports $1.5 million sold of a $10 million offering to 2 investors.
Find out what Brogent China Life Sciences Ltd. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- C/O Maples & Calder, UGLAND HOUSE PO BOX 309, Grand Cayman, Cayman Islands, KY1-1
- Phone
- (646) 694-2516
- Industry
- Other Health Care
- Entity type
- Other (Exempted Company incorporated in the Cayman Islands with Limited Liability)
- Incorporated in
- Cayman Islands
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1766809
The full lists. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 5, 2019 | New notice | $10,000,000 | $1,500,000 | $8,500,000 | 2 | Jan 22, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter John Gruber | Director | |
| Paul Louis Scibetta | Director | |
| Stephen Bernard Gruber | Director | |
| Andrew John Economos | Director |
Every Form D from the week of Feb 4, 2019 · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Brogent China Life Sciences Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.